PTC Therapeutics | PTCT - Dochód Netto





Dochód Netto Zmiana Data
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Alnylam Pharmaceuticals USD 164.49M 41.5M 2026-06
Amgen USD 2.38B 556M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Biogen USD 97.5M 222M 2026-06
BioMarin Pharmaceutical USD 44.76M 60.76M 2026-06
Cytokinetics USD -198.76M 7.27M 2026-06
Daiichi Sankyo JPY 68.64B 18B 2026-06
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Gilead Sciences USD -10.5B 12.52B 2026-06
Incyte USD 585.6M 282.27M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Novartis USD 3.26B 108M 2026-06
Pfizer USD -248M 2.94B 2026-06
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Roche Holding CHF 6.87B 1.4B 2026-06
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
TG Therapeutics USD 7.78M 12M 2026-06
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.1B 68.4M 2026-06
Xencor USD -21.73M 107.19M 2026-06